Committed to improving cardiovascular health
through innovative research and education

What can we help you find?

EXPLORE OUR

Science Centers

Complex Coronary Artery Disease Science Center

Making the impossible possible through innovative research and education around treatment approaches for the most complex of coronary artery disease cases.

Learn More

Valve Science Center

A world-class research and education center focused on innovative care and treatment for valvular heart disease, a public health crisis and life-threatening condition.

Learn More

Women’s Cardiovascular Science Center

Advance the understanding of heart and vascular disease in women, how to prevent it, and how to optimize heart health.

Learn More

Cardiovascular Learning & Innovation Center

Transform your ideas through experiential learning & collaboration with our world-class cardiovascular experts from MHI® at Abbott Northwestern Hospital

Learn More

BROWSE THE LATEST

News & Events

Events

2019 Heartbeat Gala

The stories shared will shine a light on the need for, and impact of, women’s heart health research. Join gala co-chairs, Dr. Elizabeth Grey and Dr. Retu Saxena as we lift up the impact research has on the lives of patients and their families during an evening of generosity, inspirational storytelling, and captivating guest speakers. With 600+ guests including Minneapolis Heart Institute® physicians, patients and families, thought influencers and community leaders, this evening brings our mission to life.

News

MHIF on World Heart Day

World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease, and MHIF shared in the fun! Check out the promises our staff made to be ‘heart heroes’ and how they will care for their hearts and the hearts of others. Created by the World Heart Federation, World Heart Day informs people around the globe that CVD, including heart disease and stroke, is the world’s leading cause of death claiming 17.9 million lives each year, and highlights the actions that individuals can take to prevent and control CVD.

News

MHIF at TCT2019

MHIF was well represented at the 2019 Transcatheter Cardiovascular Therapeutics conference in San Francisco in September.  37 MHI/MHIF physician and staff 58 total presentations 36 posters 11 podium presentations 9 sessions as moderators/panelists 2 lives cases

News

MHIF Researchers Help Save Lives with “Heart in a Box” Clinical Trial

MHIF is excited to be at the forefront of new clinical research that is working to find viable solutions to the problem. Since August, MHIF’s heart failure researchers, in partnership with the ANW Hospital, have completed three successful heart transplants with use of the investigational TransMedics Organ Care System (OCS™). The OCS™ Heart is a revolutionary system that preserves donor hearts, keeping them beating instead of simply storing them on ice in a cooler during transport as has been the traditional approach.

MHIF on World Heart Day

World Heart Day is the world’s biggest awareness-raising platform for cardiovascular disease, and MHIF shared in the fun! Check out the promises our staff made to be ‘heart heroes’ and how they will care for their hearts and the hearts of others. Created by the World Heart Federation, World Heart Day informs people around the globe that CVD, including heart disease and stroke, is the world’s leading cause of death claiming 17.9 million lives each year, and highlights the actions that individuals can take to prevent and control CVD.

MHIF at TCT2019

MHIF was well represented at the 2019 Transcatheter Cardiovascular Therapeutics conference in San Francisco in September.  37 MHI/MHIF physician and staff 58 total presentations 36 posters 11 podium presentations 9 sessions as moderators/panelists 2 lives cases

MHIF Researchers Help Save Lives with “Heart in a Box” Clinical Trial

MHIF is excited to be at the forefront of new clinical research that is working to find viable solutions to the problem. Since August, MHIF’s heart failure researchers, in partnership with the ANW Hospital, have completed three successful heart transplants with use of the investigational TransMedics Organ Care System (OCS™). The OCS™ Heart is a revolutionary system that preserves donor hearts, keeping them beating instead of simply storing them on ice in a cooler during transport as has been the traditional approach.

Traverse Publishes First-in-Human Porcine ECM Study Results

MHIF is proud to have been the leading enroller and clinical site in the first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that was evaluated for safety and feasibility in repairing damage and restoring cardiac function in heart failure patients who previously suffered a heart attack, sponsored by Ventrix, Inc (San Diego, CA).

Donate

Your support enables MHIF researchers to champion groundbreaking efforts to improve the cardiovascular health of individuals and communities through innovative research and education.

Donate

Newsletter


By submitting this form, you are consenting to receive marketing emails from: Minneapolis Heart Institute Foundation, 920 East 28th Street, Minneapolis, MN, 55407, http://mplsheart.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact